Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: Boplicity who wrote (2790)	6/30/2000 3:53:47 AM
From: jjkirk	Read Replies (2) \| Respond to of 13572

Mornin' Greg, Anindo said...think the best way to play the volatile biotechs is through the biotech holders BBH. Greg, you have mentioned BBH several times, but I cannot afford the 100 share minimum that Schwab requires for all "holders" shares. In biotech, I have done well with Dresdner RCM Biotech Fund (DRBNX). If you look at a comparative chart, you will see that it tracks parallel to BBH with better performance. If I remember correctly, I found DRBNX by reading The Chartist Mutual Fund Letter. siliconinvestor.com jj

To: Boplicity who wrote (2790)	6/30/2000 4:22:00 PM
From: Sam Sara	Read Replies (1) \| Respond to of 13572

An interesting spec stock that run with bios- SMMX. Same pedigree as AFFX, and I have initiated a position. biz.yahoo.com Also look at DIGL, chart looks nice. RMBS is a tough stock for me- not near support, in the air, and possble double top, but nice story. A toss up as to whether to buy at this point. Opinions? Finally, I have seen a number of failed breakouts over the past 2 weeks, just another data point, but again points to difficulty calling market direction at this point. I'm trying to hit singles at this point, and am taking profits more quickly than usual.